Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata
- PMID: 16304162
- PMCID: PMC1315975
- DOI: 10.1128/AAC.49.12.4989-4992.2005
Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata
Abstract
We investigated the fungicidal activity of caspofungin (CAS) and amphotericin B (AMB) against 16 clinical isolates of Candida glabrata. The minimum fungicidal concentrations (MFCs) of CAS were similar to those of AMB, ranging from 2.0 to >8.0 microg/ml. Time-kill assays performed on selected isolates showed that AMB was fungicidal at concentrations four times the MIC while CAS was not. A neutropenic-mouse model of disseminated infection was utilized to determine the residual fungal kidney burden. While doses as low as 0.3 and 1 mg/kg of body weight/day of CAS and AMB, respectively, were effective at reducing the counts with respect to controls, organ sterilization was reached when both drugs were administered at 5 mg/kg/day. Our study reveals that, similar to AMB, CAS has the potential for a fungicidal effect in vivo against this difficult-to-treat fungal pathogen.
Figures



Similar articles
-
Killing kinetics of caspofungin, micafungin, and amphotericin B against Candida guilliermondii.Antimicrob Agents Chemother. 2006 Aug;50(8):2829-32. doi: 10.1128/AAC.00524-06. Antimicrob Agents Chemother. 2006. PMID: 16870779 Free PMC article.
-
Caspofungin in combination with amphotericin B against Candida parapsilosis.Antimicrob Agents Chemother. 2007 Mar;51(3):941-5. doi: 10.1128/AAC.00880-06. Epub 2006 Dec 11. Antimicrob Agents Chemother. 2007. PMID: 17158939 Free PMC article.
-
Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates.Med Mycol. 2013 Jan;51(1):60-5. doi: 10.3109/13693786.2012.697198. Epub 2012 Jul 2. Med Mycol. 2013. PMID: 22746405
-
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.Rev Iberoam Micol. 2003 Dec;20(4):121-36. Rev Iberoam Micol. 2003. PMID: 15456349 Review.
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
Cited by
-
Changes in cell wall synthesis and ultrastructure during paradoxical growth effect of caspofungin on four different Candida species.Antimicrob Agents Chemother. 2011 Jan;55(1):302-10. doi: 10.1128/AAC.00633-10. Epub 2010 Nov 8. Antimicrob Agents Chemother. 2011. PMID: 21060107 Free PMC article.
-
Mechanisms of echinocandin antifungal drug resistance.Ann N Y Acad Sci. 2015 Sep;1354(1):1-11. doi: 10.1111/nyas.12831. Epub 2015 Jul 17. Ann N Y Acad Sci. 2015. PMID: 26190298 Free PMC article. Review.
-
In Vitro Susceptibility Tests in the Context of Antifungal Resistance: Beyond Minimum Inhibitory Concentration in Candida spp.J Fungi (Basel). 2023 Dec 12;9(12):1188. doi: 10.3390/jof9121188. J Fungi (Basel). 2023. PMID: 38132789 Free PMC article. Review.
-
Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments.Antimicrob Agents Chemother. 2006 Jul;50(7):2569-72. doi: 10.1128/AAC.00291-06. Antimicrob Agents Chemother. 2006. PMID: 16801448 Free PMC article.
-
Deciphering Candida auris Paradoxical Growth Effect (Eagle Effect) in Response to Echinocandins.Methods Mol Biol. 2022;2517:73-85. doi: 10.1007/978-1-0716-2417-3_6. Methods Mol Biol. 2022. PMID: 35674946
References
-
- Bartizal, K., C. J. Gill, G. K. Abruzzo, A. M. Flattery, L. Kong, P. M. Scott, J. G. Smith, C. E. Leighton, A. Bouffard, J. F. Dropinski, and J. Balkovec. 1997. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob. Agents Chemother. 41:2326-2332. - PMC - PubMed
-
- Cantón, E., J. Pemán, A. Viudes, G. Quindós, M. Gobernado, and A. Espinel-Ingroff. 2003. Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species. Diagn. Microbiol. Infect. Dis. 45:203-206. - PubMed
-
- Colombo, A. L., J. Perfect, M. DiNubile, K. Bartizal, M. Motyl, P. Hicks, R. Lupinacci, C. Sable, and N. Kartsonis. 2003. Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis. Eur. J. Clin. Microbiol. Infect. Dis. 22:470-474. - PubMed
-
- Deresinski, S. C., and D. A. Stevens. 2003. Caspofungin. Clin. Infect. Dis. 36:1445-1457. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources